Tanning as a behavioral addiction

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 5, 2010, Pages 284-290

  Kourosh, Arianne S ^a   Harrington, Cynthia R ^a   Adinoff, Bryon ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Addictive; Behavior; Compulsive; Light; Ultraviolet radiation

Indexed keywords

CARCINOGEN; NALTREXONE;

ADDICTION; BEHAVIOR; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MENTAL DISEASE; MOOD DISORDER; REINFORCEMENT; REVIEW; REWARD; SKIN COLOR; SUBSTANCE ABUSE; SUNBATHING; SUNTAN; SYMPTOM; ULTRAVIOLET RADIATION;

BEHAVIOR, ADDICTIVE; FEMALE; HUMANS; MENTAL DISORDERS; QUESTIONNAIRES; SKIN NEOPLASMS; SUBSTANCE-RELATED DISORDERS; SUNBATHING; ULTRAVIOLET RAYS;

EID: 77956311445     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2010.491883     Document Type: Review

References (59)

1. McClung AA, Uchida T, Wagner RFJ. Body dysmorphic disorder and substance-related disorder among indoor tanners. Skin Cancer 2008; 23:17-22.
2. Nolan BV, Feldman SR. Ultraviolet tanning addiction. Dermatologic Clinics 2009; 27:109-112.
3. Harrington CR, Beswick TC, Leitenberger J, Minhajuddin A, Jacobe HT, Adinoff B. Addictive-like behaviors to ultraviolet light among frequent indoor tanners. Clin Exp Dermatol 2010; (in press).
4. WHO. Ultraviolet radiation and human health. 2009; . who.int/mediacentre/ factsheets/fs305/en/index.html (Assessed May 27, 2010).
5. Lucas R, McMichael T, Smith W, Armstrong B. Solar Ultraviolet Radiation: Global burden of disease from solar ultraviolet radiation. Environmental Burden of Disease Series, No.13. Pruss-U stun A, Zeeb H, Mathers C, Repacholi M. Geneva: World Health Organization, 2006.
6. Saraiya M, Hall HI, Uhler RJ. Sunburn prevalence among adults in the United States, 1999. Am J Prev Med 2002; 23:91-97.
7. Davis KJ, Cokkinides VE, Weinstock MA, OConnell MC, Wingo PA. Summer sunburn and sun exposure among U.S. youths ages 11 to 18: National prevalence and associated factors. Pediatrics 2002; 110:27-35.
8. Geller AC, Colditz G, Oliveria S, Emmons K, Jorgensen C, Aweh GN, Frazier AL. Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 U.S. children and adolescents. Pediatrics 2002; 109:1009-1014.
9. Weinstock MA, Rossi JS, Redding CA, Maddock JE, Cottrill SD. Sun protection behaviors and stages of change for the primary prevention of skin cancers among beachgoers in southeastern New England. Ann Behav Med 2000; 22:286-293.
10. Levine JA, Sorace M, Spencer J, Siegel DM. The indoor UV tanning industry: A review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol 2005; 53:1038-1044.
11. AAD. Research Shows Popularity of Indoor Tanning Contributes to Increased Incidence of Skin Cancer 2006; media/background/jaad/jaad increase skin cancer 12 05.html (Assessed May 27, 2010).
12. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14:562-566.
13. Mawn VB, Fleischer AB, Jr. A survey of attitudes, beliefs, and behavior regarding tanning bed use, sunbathing, and sunscreen use. Journal of the American Academy of Dermatology 1993; 29:959-962.
14. Robinson JK, Rademaker AW, Sylvester JA, Cook B. Summer sun exposure: knowledge, attitudes, and behaviors of Midwest adolescents. Prev Med 1997; 26:364-372.
15. Arthey S, Clarke VA. Suntanning and sun protection: A review of the psychological literature. Soc Sci Med 1995; 40:265-274.
16. Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997; 37:179-186.
17. Westerdahl J, OlssonH,Masback A, Ingvar C, JonssonN,Brandt L, Jonsson PE, Moller T. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 1994; 140(8):691-699.
18. Bergenmar M, Brandberg Y. Sunbathing and sun-protection behaviors and attitudes of young Swedish adults with hereditary risk for malignant melanoma. Cancer Nurs. 2001; 24(5):341-350.
19. Warthan MM, Uchida T, Wagner RF, Jr. UV light tanning as a type of substance-related disorder. Arch Dermatol 2005; 141(8):963-966.
20. Poorsattar SP, Hornung RL. UV light abuse and high-risk tanning behavior among undergraduate college students. Journal of the American Academy of Dermatology. 2007; 56(3):375-379.
21. Phillips KA, Conroy M, Dufresne RG, Menard W, Didie ER, Hunter-Yates J, Fay C, Pagano M. Tanning in body dysmorphic disorder. Psychiatr Q. 2006; 77(2):129-138.
22. Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope 1997; 107(7):888-892.
23. Zeller S, Lazovich D, Forster J, Widome R. Do adolescent indoor tanners exhibit dependency? J Am Acad Dermatol 2006; 54(4):589-596.
24. Hunter-Yates J, Dufresne RG Jr, Phillips KA. Tanning in body dysmorphic disorder. J Am Acad Dermatol 2007; 56(5 Suppl):S107-109.
25. Neinstein LJM, Shapiro J. Psychosocial development in normal adolescents. Adolescent Health Care: A Practical Guide. Baltimore:Williams and Wilkins, 1996, pp. 42-44.
26. Feldman SR, Liguori A, Kucenic M, Rapp SR, Fleischer AB Jr, Lang W, Kaur M. Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol 2004; 51(1):45-51.
27. Prevention NCoSC. Newslink on Skin Cancer Prevention. 2002; http:// www.skincancerprevention.org/Portals/0/pdf/newslink issue7.pdf (Assessed May 27, 2010).
28. Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr, Feldman SR. Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol 2006; 54(4):709-711.
29. Kaur M, Liguori A, Fleischer AB Jr, Feldman SR. Side effects of naltrexone observed in frequent tanners: Could frequent tanners have ultravioletinduced high opioid levels? Journal of the American Academy of Dermatology 2005; 52(5):916.
30. Holick MF. Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006; 354(21):2287-2288; author reply.
31. Millington GW. Proopiomelanocortin (POMC): The cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 2006; 31(3):407-412.
32. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: From physiology to pathological conditions. Eur J Endocrinol 2003; 149(2):79-90.
33. Pathak MA, Fanselow DL. Photobiology of melanin pigmentation: Dose/response of skin to sunlight and its contents. J Am Acad Dermatol 1983; 9(5):724-733.
34. Riley PA. Melanin. Int J Biochem Cell Biol 1997; 29(11):1235-1239.
35. Bykov VJ, Marcusson JA, Hemminki K. Effect of constitutional pigmentation on ultraviolet B-induced DNA damage in fair-skinned people. J Invest Dermatol 2000; 114(1):40-43.
36. Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, DOrazio J, Fung CY, Schanbacher CF, Granter SR, Fisher DE. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007; 128(5):853-864.
37. Kaur M, Feldman SR, Liguori A, Fleischer AB Indoor tanning relieves pain. Photodermatol Photoimmunol Photomed 2005; 21(5):278.
38. Bigliardi PL, Bigliardi-QiM, Buechner S, Rufli T. Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 1998; 111(2):297-301.
39. Wintzen M, de Winter S, Out-Luiting JJ, van Duinen SG, Vermeer BJ. Presence of immunoreactive beta-endorphin in human skin. Exp Dermatol 2001; 10(5):305-311.
40. Kaur M, Liguori A, Fleischer AB Jr, Feldman SR. Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. Journal of the American Academy of Dermatology 2006; 54(5):919-920.
41. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L. Is p53 polymorphism maintained by natural selection? Hum Hered 1994; 44(5):266-270.
42. Oren M, Bartek J. The sunny side of p53. Cell 2007; 128(5):826-828.
43. Klein DC,Weller JL,Moore RY. Melatonin metabolism: Neural regulation of pineal serotonin: Acetyl coenzyme A N-acetyltransferase activity. Proc Natl Acad Sci USA 1971; 68(12):3107-3110.
44. Uz T, Manev H. Prolonged swim-test immobility of serotonin N-acetyltransferase (AANAT)-mutant mice. J Pineal Res 2001; 30(3):166-170.
45. Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ. Effects of melatonin on human mood and performance. Brain Res 1984; 323(2):201-207.
46. Golus P, King MG. The effects of melatonin on open field behavior. Pharmacol Biochem Behav 1981; 15(6):883-885.
47. Wehr TA, Duncan WC Jr, Sher L, Aeschbach D, Schwartz PJ, Turner EH, Postolache TT, Rosenthal NE. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry 2001; 58(12):1108-1114.
48. Bondareff W, Gordon B. Submicroscopic localization of norepinephrine in sympathetic nerves of rat pineal. J Pharmacol Exp Ther 1966; 153(1):42-47.
49. Klein DC, Weller JL. Indole metabolism in the pineal gland: A circadian rhythm in N-acetyltransferase. Science 1970; 169(950):1093-1095.
50. Roecklein KA, Rohan KJ, Duncan WC, Rollag MD, Rosenthal NE, Lipsky RH, Provencio I. A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder. Journal of Affective Disorders 2009; 114(1-3):279-285.
51. Berson DM. Phototransduction in ganglion-cell photoreceptors. Pflugers Archiv. European Journal of Physiology 2007; 454(5):849-855.
52. Moore RY, Klein DC. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Research 1974; 71(1):17-33.
53. Brownstein M, Axelrod J. Pineal gland: 24-hour rhythm in norepinephrine turnover. Science 1974; 184(133):163-165.
54. Lundt L. Modafinil treatment in patients with seasonal affective disorder/ winter depression: an open-label pilot study. J Affect Disord 2004; 81(2):173-178.
55. Wehr TA, Giesen HA, Schulz PM, Anderson JL, Joseph-Vanderpool JR, Kelly K, Kasper S, Rosenthal NE. Contrasts between symptoms of summer depression and winter depression. J Affect Disord 1991; 23(4):173-183.
56. Hillhouse J, Stapleton J, Turrisi R. Association of frequent indoor UV tanning with seasonal affective disorder. Arch Dermatol 2005; 141(11):1465.
57. Kong LD, Tan RX,Woo AY, Cheng CH. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: Implications for the treatment of affective disorders. Pharmacol Toxicol 2001; 88(2):75-80.
58. Barsh G, Attardi LD. A healthy tan? N Engl J Med 2007; 356(21):2208-2210.
59. Gilchrest BA. Sun protection and Vitamin D: Three dimensions of obfuscation. J Steroid Biochemistry and Molecular Biology 2007; 103(3-5):655-663.